Zlbbehring.com provides information for people with rare and serious diseases
Title
ZLB Behring Homepage
Description
About ZLB Behring
ZLB Behring is one of the world’s leading pharmaceutical companies specializing in the manufacture of plasma products. Its comprehensive line of therapies include products for the treatment of hemophilia and other coagulation disorders, immunoglobulins for the prevention and treatment of immune disorders, treatments that inhibit the formation of blood clots, wound-healing agents used during major surgical procedures, and plasma expanders for the treatment of a variety of conditions such as shock, burns and circulatory disorders. Additionally, ZLB Behring operates one of the world’s largest, fully-owned plasma collection networks.
ZLB Behring is committed to developing the next generation of therapeutic proteins to meet the demands of the evolving market. Products under development include subcutaneous immunoglobulin treatment for primary immune deficiency and fibrin dressings for use in cases of severe hemorrhage.
At plants located in Bern, Switzerland; Marburg, Germany; and Kankakee, Illinois, ZLB Behring manufactures therapies in accordance with international safety and quality standards. The products are distributed worldwide. In 2007 ZLB Behring adopted the name CSL Behring. [1]
